A new article by Fierce Healthcare titled “A new wave of middlemen offers ‘alternative funding’ for specialty drugs. Patients bear the risks” highlights the harm patients can experience when being required to work with an alternative funding vendor. After conducting more than four dozen interviews with patients and patient advocates, clinicians, attorneys, pharmaceutical companies, drug pricing experts, brokers, pharmacy benefit managers and public officials, the article provides a thorough overview of how AFPs apply consumers to patient assistance programs, delay access to care, and, in some cases, require the use of international importation. Read the full article here.
Last Updated on October 23, 2025 by Aimed Alliance
